WT
UTHR icon

Whittier Trust’s United Therapeutics UTHR Stock Holding History

Whittier Trust’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4K Hold
41
– – ﹤0.01% 1002
2026
Q1 		$22.9K Hold
41
– – ﹤0.01% 978
2025
Q4 		$20.6K Hold
41
– – ﹤0.01% 1020
2025
Q3 		$18.6K Hold
41
– – ﹤0.01% 1015
2025
Q2 		$11.8K Hold
41
– – ﹤0.01% 1208
2025
Q1 		$12.6K Hold
41
– – ﹤0.01% 1188
2024
Q4 		$14.5K Hold
41
– – ﹤0.01% 1185
2024
Q3 		$14.7K Hold
41
– – ﹤0.01% 1189
2024
Q2 		$13.1K Buy
+41
New +$10.9K ﹤0.01% 1198
2023
Q4 		– Sell
-7
Closed -$1.58K – 1680
2023
Q3 		$1.58K Buy
+7
New +$1.61K ﹤0.01% 1487

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Whittier Trust's UTHR Position: Q2 2026 in Review

Whittier Trust held its United Therapeutics (UTHR) position steady in Q2 2026 at 41 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Whittier Trust first reported a position in UTHR in Q3 2023 and has held it in 10 quarters since. The position peaked at $22.9K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Whittier Trust held 41 shares of United Therapeutics worth $22.4K as of Q2 2026.
  • Whittier Trust left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #1002 holding.
  • Whittier Trust first reported a position in United Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • Whittier Trust's United Therapeutics position peaked at $22.9K in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.